Skip To Main Content

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
ASMD Phenotypes

ASMD Phenotypes

Understanding Time-in-Range: Assessment, Targets, and Benefits for Optimal Glycemic Control

Understanding Time-in-Range: Assessment, Targets, and Benefits for Optimal Glycemic Control

Real-world evidence of treatment intensification in people with T2D inadequately controlled on GLP-1 RAs

Real-world evidence of treatment intensification in people with T2D inadequately controlled on GLP-1 RAs

ADA 2021: Solimix Trial Summary

ADA 2021: Solimix Trial Summary

Regulate LDL-C level for those undergoing coronary revascularization (Diabetic Patients)

Regulate LDL-C level for those undergoing coronary revascularization (Diabetic Patients)

Prophylactic Strategies for VTE in Gynecologic Cancer Patients

Prophylactic Strategies for VTE in Gynecologic Cancer Patients

Diabetes your type: Testimonial by Dr. Nadia

Diabetes your type: Testimonial by Dr. Nadia

Diabetes your type: Testimonial by Dr. Hussein​

Diabetes your type: Testimonial by Dr. Hussein​

BI hormonal CL systems

BI hormonal CL systems

Optimal use of LLT after ACS

Optimal use of LLT after ACS

LDL-C in the management of high cardiovascular risk, changing the paradigm for prevention

LDL-C in the management of high cardiovascular risk, changing the paradigm for prevention

The Lixilan-L Study

The Lixilan-L Study